Advanced searches left 3/3
Search only database of 7.4 mil and more summaries

Ebola Vaccine

Summarized by PlexPage
Last Updated: 20 September 2021

* If you want to update the article please login/register

General | Latest Info

Ebola Vaccine

Clinical data
ATC codeJ07BX02 ( WHO )
Trade namesErvebo, Zabdeno, Mvabea
Identifiers
CAS Number2581749-86-0
Legal status
Legal statusUS : -only, EU : Rx-only
Vaccine description
TargetEbola virus
Vaccine typeViral vector

A efficient and secure vaccine is a vital device to protect frontline workers and prevent the introduction and spread of Ebola in the United States.

The Ebola virus is a zoonotic virus that creates serious hemorrhagic high temperature in human beings, referred to as Ebola infection condition. The stockpiled Ervebo can be provided for pre-exposure vaccination of people who fall into among the three work-related classifications: Ebola infection disease -responders: Individuals responding to a break out due to Ebola virus. Employees working at non-BSL-4 centers busy Response Network might be qualified to obtain Ervebo depending on certain scenarios of public health and wellness demands and the Ebola readiness and/or response tasks at such facilities.

Medical care workers *: HCP at government assigned Ebola Treatment Centers involved in the care and transport of patients infected or believed to be infected with the Ebola virus.

While the risk of Ebola virus illness in the US stays low, the United States federal government remains deeply committed to combating ravaging Ebola break outs in Africa, consisting of the present break out in the Democratic Republic of the Congo, said Anna Abram, FDA Deputy Commissioner for Policy, Legislation, and International Affairs. People that give take care of people with EVD, consisting of wellness care workers who do not use right infection control safety measures, go to the highest possible danger for infection. On uncommon events, people become ill with EVD after coming into direct contact with infected animals, which can after that result in EVD break outs when the virus spreads out between people. No situations of EVD with sign start greater than 10 days after vaccination were observed in the instant collection group, contrasted with 10 cases of EVD in the 21-day delayed cluster group.

In the early 1990s, a Yale University researcher named John Jack Rose was attempting to identify a way to use a livestock virus called vesicular stomatitis infection, or VSV, as a vaccine distribution system. Klenk said that, even after that, there was some discussion about whether the hybrid VSV virus can be made right into Ebola or Marburg vaccines. And when he left Germany in 1999, he asked Klenk if he might take the VSV construct with him, so he could continue his work. Feldmann and Geisbert, an Ebola expert who was after that at the US Army Medical Research Institute of Infectious Diseases, thought Nabel was incorrect which they can make use of the VSV construct to confirm it. All the mice that had been infected with the VSV infection lugging the glycoprotein were completely protected from illness; the mice that had not been exposed to the VSV infection all passed away.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

Related video

24 March 2017The Story of our Ebola Vaccine

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Ebola Vaccine (latest news)

Johnson & Johnson's two-dose vaccine routine versus Ebola is safe and creates a strong immune response in people 1 years of age and older, according to two research studies released this week in The Lancet Infectious Diseases.

May 13 2021-Johnson & Johnson announced the World Health Organization and the federal government of Sierra Leone have started administering the Company's Ebola vaccine regimen as component of a WHO early accessibility clinical program to stop more spread of Ebola in West Africa. Wellness authorities in Guinea formally proclaimed a new Ebola outbreak on February 2021 after the West African country experienced its first instances of disease since the end of the 2014-2016 Ebola episode. It is also the first research study assessing the Johnson & Johnson Ebola vaccine regimen in a randomized, double-blind, controlled trial in a pediatric population.

The research studies outlined the outcomes of stage 2 randomized, managed trials in Sierra Leone, which is among the 3 nations that was struck hard during the huge 2014-16 West African Ebola outbreak.

Johnson & Johnson's vaccine regimen consists of a dose of the adenovirus vector-based vaccine Ad26. ZEBOV adhered to 8 weeks later on by a different vector-based vaccine called the MVA-BN-Filo. Data showed that 98% of the immunized grownups 18 to 69 years old industrialized immune responses 21 days after the 2nd vaccination geometric mean binding antibody concentration of 4784 ELISA devices per milliliter in phase 1 and 3810 EU/mL in phase 2.

To day, greater than 250000 people getting involved in professional tests and vaccination initiatives have obtained at the very least the first dosage of the Johnson & Johnson vaccine program, according to the LSHTM press release.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summarized are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo
jooble logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.